Calgary, Alberta – March 18, 2025 - TheNewswire – nDatalyze Corp. (“NDAT” or the “Corporation”) (CSE:NDAT) (OTCQB:NDATF) announces that both Parties remain committed to completing the previously-announced RTO with ThriveTech Holdings. Conversations are ongoing with the Canadian Securities Exchange (“CSE”) related to various matters in advance of signing the formal binding agreement. To the Corporation’s knowledge, the primary outstanding issue relates to the post-RTO ratio of shares held by pre-RTO NDAT shareholders versus the percentage of shares held by the new incoming shareholders. While NDAT management is seeking to accelerate the resolution of all issues, the resolution timeframe remains unknown.

 

On the technical side, work progresses toward releasing a new product line that addresses the electronic medical record (“EMR”) market, the Concierge medical market and the Performance Coaching market. The new offering, called Sigmund, incorporates NDAT’s expert-guided, AI-augmented mental condition assessment and a proprietary DNA panel containing numerous scientifically-identified mental condition markers. Sigmund is essentially complete with the final reports and new website in the final stages.

 

For Further Information, please contact:

 

Jim Durward, President, CEO/CTO

Email: jimd@ndatalyze.com    

nDatalyze Website: https://www.ndatalyze.com      

 

Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release. This news release does not constitute an offer to sell or a solicitation of an offer to sell any of the securities in the United States. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the "U.S. Securities Act") or any state securities laws and may not be offered or sold within the United States or to U.S. Persons unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration is available. The information in this news release includes certain information and statements about management's view of future events, expectations, plans and prospects that constitute forward looking statements. These statements are based upon assumptions that are subject to significant risks and uncertainties. Because of these risks and uncertainties and as a result of a variety of factors, the actual results, expectations, achievements or performance may differ materially from those anticipated and indicated by these forward-looking statements. Any number of factors could cause actual results to differ materially from these forward-looking statements as well as future results. Although the Corporation believes that the expectations reflected in forward looking statements are reasonable, it can give no assurances that the expectations of any forward-looking statements will prove to be correct. Except as required by law, the Corporation disclaims any intention and assumes no obligation to update or revise any forward-looking statements to reflect actual results, whether as a result of new information, future events, changes in assumptions, changes in factors affecting such forward-looking statements or otherwise.